BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31194698)

  • 21. Chronic diastolic stretch unmasks conduction defects in an in vitro model of arrhythmogenic cardiomyopathy.
    Ng R; Gokhan I; Stankey P; Akar FG; Campbell SG
    Am J Physiol Heart Circ Physiol; 2023 Oct; 325(6):H1373-85. PubMed ID: 37830983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockout of SORBS2 Protein Disrupts the Structural Integrity of Intercalated Disc and Manifests Features of Arrhythmogenic Cardiomyopathy.
    Ding Y; Yang J; Chen P; Lu T; Jiao K; Tester DJ; Giudicessi JR; Jiang K; Ackerman MJ; Li Y; Wang DW; Lee HC; Wang DW; Xu X
    J Am Heart Assoc; 2020 Sep; 9(17):e017055. PubMed ID: 32808564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.
    Chen K; Song J; Wang Z; Rao M; Chen L; Hu S
    Clin Cardiol; 2018 May; 41(5):615-622. PubMed ID: 29750433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair.
    Alcalai R; Metzger S; Rosenheck S; Meiner V; Chajek-Shaul T
    J Am Coll Cardiol; 2003 Jul; 42(2):319-27. PubMed ID: 12875771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creating a 'Molecular Band-Aid'; Blocking an Exposed Protease Target Site in Desmoplakin.
    Hoover CA; Ott KL; Manring HR; Dew T; Borzok MA; Wright NT
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34065787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies.
    Piriou N; Marteau L; Kyndt F; Serfaty JM; Toquet C; Le Gloan L; Warin-Fresse K; Guijarro D; Le Tourneau T; Conan E; Thollet A; Probst V; Trochu JN
    ESC Heart Fail; 2020 Aug; 7(4):1520-1533. PubMed ID: 32356610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmogenic dilated cardiomyopathy due to a novel mutation in the desmoplakin gene.
    Krishnamurthy S; Adhisivam B; Hamilton RM; Baskin B; Biswal N; Kumar M
    Indian J Pediatr; 2011 Jul; 78(7):866-9. PubMed ID: 21193976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype Correlates in Arrhythmogenic Cardiomyopathies.
    Murray B; James CA
    Curr Cardiol Rep; 2022 Nov; 24(11):1557-1565. PubMed ID: 36074218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report of a Spanish patient with arrhythmogenic right ventricular cardiomyopathy and palmoplantar keratoderma without plakoglobin and desmoplakin gene modifications.
    Alonso-Orgaz S; Zamorano-León JJ; Fernandez-Arquero M; Villacastín J; Perez-Castellanos N; García-Torrent MJ; Macaya C; López Farré AJ
    Int J Cardiol; 2007 May; 118(2):275-7. PubMed ID: 17045679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma.
    Williams T; Machann W; Kühler L; Hamm H; Müller-Höcker J; Zimmer M; Ertl G; Ritter O; Beer M; Schönberger J
    Clin Res Cardiol; 2011 Dec; 100(12):1087-93. PubMed ID: 21789513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy?
    Kukavica D; Trancuccio A; Arnò C; Latini AC; Mazzanti A; Priori SG
    Minerva Cardiol Angiol; 2022 Apr; 70(2):217-237. PubMed ID: 34338490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Novel Homozygous Desmoplakin Mutations in Carvajal Syndrome.
    Molho-Pessach V; Sheffer S; Siam R; Tams S; Siam I; Awwad R; Babay S; Golender J; Simanovsky N; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2015; 32(5):641-6. PubMed ID: 25824144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmoplakin mutations with palmoplantar keratoderma, woolly hair and cardiomyopathy.
    Pigors M; Schwieger-Briel A; Cosgarea R; Diaconeasa A; Bruckner-Tuderman L; Fleck T; Has C
    Acta Derm Venereol; 2015 Mar; 95(3):337-40. PubMed ID: 25227139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
    Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
    Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity.
    Brandão M; Bariani R; Rigato I; Bauce B
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome.
    Uzumcu A; Norgett EE; Dindar A; Uyguner O; Nisli K; Kayserili H; Sahin SE; Dupont E; Severs NJ; Leigh IM; Yuksel-Apak M; Kelsell DP; Wollnik B
    J Med Genet; 2006 Feb; 43(2):e5. PubMed ID: 16467215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (
    Hoorntje ET; Burns C; Marsili L; Corden B; Parikh VN; Te Meerman GJ; Gray B; Adiyaman A; Bagnall RD; Barge-Schaapveld DQCM; van den Berg MP; Bootsma M; Bosman LP; Correnti G; Duflou J; Eppinga RN; Fatkin D; Fietz M; Haan E; Jongbloed JDH; Hauer AD; Lam L; van Lint FHM; Lota A; Marcelis C; McCarthy HJ; van Mil AM; Oldenburg RA; Pachter N; Planken RN; Reuter C; Semsarian C; van der Smagt JJ; Thompson T; Vohra J; Volders PGA; van Waning JI; Whiffin N; van den Wijngaard A; Amin AS; Wilde AAM; van Woerden G; Yeates L; Zentner D; Ashley EA; Wheeler MT; Ware JS; van Tintelen JP; Ingles J
    Circ Genom Precis Med; 2023 Feb; 16(1):e003672. PubMed ID: 36580316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmogenic cardiomyopathy.
    Pilichou K; Thiene G; Bauce B; Rigato I; Lazzarini E; Migliore F; Perazzolo Marra M; Rizzo S; Zorzi A; Daliento L; Corrado D; Basso C
    Orphanet J Rare Dis; 2016 Apr; 11():33. PubMed ID: 27038780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Rouhi L; Fan S; Cheedipudi SM; Braza-Boïls A; Molina MS; Yao Y; Robertson MJ; Coarfa C; Gimeno JR; Molina P; Gurha P; Zorio E; Marian AJ
    Cardiovasc Res; 2022 May; 118(6):1466-1478. PubMed ID: 34132777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmogenic cardiomyopathy: a disease of intercalated discs.
    Calore M; Lorenzon A; De Bortoli M; Poloni G; Rampazzo A
    Cell Tissue Res; 2015 Jun; 360(3):491-500. PubMed ID: 25344329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.